# Real-world Study of Dedifferentiated Liposarcoma Patients in China

> **NCT06115681** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 1390 (actual)

## Conditions studied

- Dedifferentiated Liposarcoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06115681
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-13
- **Primary completion:** 2024-05-15
- **Final completion:** 2024-05-15
- **Target enrollment:** 1390 (ACTUAL)
- **Last updated:** 2025-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06115681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06115681, "Real-world Study of Dedifferentiated Liposarcoma Patients in China". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06115681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*